Act Capital Management, LLC Cyteir Therapeutics, Inc. Transaction History

Act Capital Management, LLC

  • $72.5 Million
  • Q3 2022

A detailed history of Act Capital Management, LLC transactions in Cyteir Therapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 15,000 shares of CYT stock, worth $45,150. This represents 0.04% of its overall portfolio holdings.

Number of Shares
15,000
Previous 15,000 -0.0%
Holding current value
$45,150
Previous $45,000 35.56%
% of portfolio
0.04%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
BUY
$14.57 - $21.86 $217,238 - $325,932
14,910 Added 16566.67%
15,000 $263,000
Q2 2021

Aug 16, 2021
BUY
$16.8 - $21.4 $1,512 - $1,925
90 New
90 $2,000

Others Institutions Holding CYT

# of Institutions
2
Shares Held
2.47M
Call Options Held
0
Put Options Held
0
View Full List

About Cyteir Therapeutics, Inc.

CYT Quotes by TradingView
  • Ticker CYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,413,400
  • Market Cap $107M
  • Description
  • Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...
More about CYT
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email